KCNJ13 Protein (Kir7.1 Potassium Channel)
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">KCNJ13 Protein (Kir7.1 Potassium Channel)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>KCNJ13</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>KCNJ13 (Kir7.1 Potassium Channel)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=KCNJ13" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
[KCNJ13 protein](/proteins/kcnj13-protein) (Kir7.1) is an inward-rectifier potassium channel encoded by [KCNJ13](/genes/kcnj13). Kir7.1 contributes to potassium homeostasis, membrane potential stability, and epithelial transport across polarized tissues, especially retinal pigment epithelium and related barrier compartments.[@hibino2010][@nichols1997] In neurodegeneration modeling, Kir7.1 is not a primary monogenic driver of common disorders such as [Alzheimer's disease](/diseases/alzheimers-disease) or [Parkinson's disease](/diseases/parkinsons-disease), but it is relevant as an excitability and bioenergetic stress modifier that can influence downstream vulnerability pathways.[@staley2015][@surmeier2017]
Protein Architecture
Kir7.1 follows the canonical inward-rectifier channel architecture:
...KCNJ13 Protein (Kir7.1 Potassium Channel)
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">KCNJ13 Protein (Kir7.1 Potassium Channel)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>KCNJ13</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>KCNJ13 (Kir7.1 Potassium Channel)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=KCNJ13" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
[KCNJ13 protein](/proteins/kcnj13-protein) (Kir7.1) is an inward-rectifier potassium channel encoded by [KCNJ13](/genes/kcnj13). Kir7.1 contributes to potassium homeostasis, membrane potential stability, and epithelial transport across polarized tissues, especially retinal pigment epithelium and related barrier compartments.[@hibino2010][@nichols1997] In neurodegeneration modeling, Kir7.1 is not a primary monogenic driver of common disorders such as [Alzheimer's disease](/diseases/alzheimers-disease) or [Parkinson's disease](/diseases/parkinsons-disease), but it is relevant as an excitability and bioenergetic stress modifier that can influence downstream vulnerability pathways.[@staley2015][@surmeier2017]
Protein Architecture
Kir7.1 follows the canonical inward-rectifier channel architecture:
- Two transmembrane helices (M1 and M2)
- One pore-forming loop with selectivity filter
- Cytosolic N- and C-terminal regions that regulate gating and assembly
- Tetrameric channel assembly for functional conductance
Unlike many high-conductance Kir channels, Kir7.1 has atypical current-voltage properties and pharmacology, with relatively specialized behavior in epithelial microenvironments.[@hibino2010][@nichols1997] This matters for disease biology because localized ion gradients at barrier interfaces can determine whether tissue remains resilient or shifts toward inflammatory and metabolic stress states.
Physiologic Function
Potassium Homeostasis and Membrane Stability
Kir-family channels buffer resting membrane potential and shape excitability reserve. Even modest reductions in effective potassium buffering can increase spontaneous depolarization burden and calcium entry pressure.[@hibino2010][@staley2015] In systems-level neurodegeneration models, this creates upstream pressure on [calcium homeostasis disruption](/mechanisms/calcium-homeostasis-disruption), [mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction), and [oxidative stress](/mechanisms/oxidative-stress).
Interface Tissue Support
Kir7.1 is most strongly established in retinal and epithelial physiology. At these interfaces, potassium transport and electrochemical gradients affect photoreceptor support, fluid movement, and tissue homeostasis.[@nichols1997][@sergouniotis2013] The mechanistic principle generalizes to brain barrier biology: disrupted ionic regulation at support interfaces can amplify chronic neuroinflammatory signaling and metabolic strain.[@surmeier2017][@swerdlow2018]
Systems Coupling to Neurodegeneration Pathways
Ion-channel dysfunction often converges with three core cascades seen across neurodegeneration:
Excitability stress and abnormal firing dynamics
ATP-demand mismatch and mitochondrial overload
Redox imbalance and inflammatory amplificationFor Kir7.1, the strongest evidence is indirect systems coupling rather than direct disease causation in major neurodegenerative cohorts.[@staley2015][@surmeier2017][@swerdlow2018]
Disease-Relevant Evidence
Inherited Retinal Degeneration
Human genetics provides the clearest high-confidence signal for KCNJ13/Kir7.1 biology. Biallelic pathogenic variants cause severe early-onset retinal degeneration phenotypes, demonstrating that durable Kir7.1 dysfunction can drive neural tissue injury in high-demand sensory systems.[@sergouniotis2013]
Neurodegeneration Context
Current evidence supports interpreting Kir7.1 as:
- A mechanistic modifier of excitability and ion-homeostasis burden
- A potential stratification feature in ion-channel-focused biomarker panels
- A network node that may affect resilience rather than a stand-alone disease trigger
This framing is consistent with selective-vulnerability models in which baseline ionic and metabolic stress predisposes specific circuits to degeneration over time.[@staley2015][@surmeier2017]
Translational Implications
No CNS-approved therapy specifically targets Kir7.1 for neurodegeneration. Practical translational directions include:
- Electrophysiology-informed subgrouping in trials where network hyperexcitability affects outcome
- Combination designs pairing excitability modulation with mitochondrial or anti-inflammatory strategies
- Longitudinal biomarker frameworks that align channel physiology with progression trajectories
Because strongest human causal evidence is currently retinal, extrapolation to AD/PD/ALS should remain hypothesis-driven and explicitly uncertainty-labeled.[@surmeier2017][@swerdlow2018]
Research Priorities
- Map Kir7.1 expression and compensation across vulnerable human cell populations
- Quantify whether KCNJ13 variants modify progression in major neurodegenerative cohorts
- Test whether Kir7.1-relevant excitability correction reduces mitochondrial and inflammatory stress readouts
- Integrate Kir-channel features into multiscale disease models linking ion flux, energetics, and glial reactivity
See Also
- [KCNJ13 Gene](/genes/kcnj13)
- [Ion channel dysfunction](/mechanisms/ion-channel-dysfunction)mechanisms/ion-channel-dysfunction-neurodegeneration)
- [Calcium homeostasis disruption](/mechanisms/calcium-homeostasis-disruption)
- [Mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction)
- [Oxidative stress](/mechanisms/oxidative-stress)
- [Neuroinflammation](/mechanisms/neuroinflammation)
External Links
- [UniProt: KCNJ13/Kir7.1](https://www.uniprot.org/uniprotkb/O60928/entry)
- [NCBI Gene: KCNJ13](https://www.ncbi.nlm.nih.gov/gene/3765)
References
[Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, Kurachi Y, Inwardly rectifying potassium channels: their structure, function, and physiological roles (2010)](https://pubmed.ncbi.nlm.nih.gov/18287056/)
[Nichols CG, Lopatin AN, Inward rectifier potassium channels (1997)](https://pubmed.ncbi.nlm.nih.gov/10625698/)
[Staley K, Molecular mechanisms of epilepsy (2015)](https://pubmed.ncbi.nlm.nih.gov/20478528/)
[Surmeier DJ, Obeso JA, Halliday GM, Selective neuronal vulnerability in Parkinson disease (2017)](https://pubmed.ncbi.nlm.nih.gov/25442937/)
[Sergouniotis PI, Davidson AE, Mackay DS, et al, Biallelic mutations in KCNJ13 cause a severe retinal degenerative disease with onset in childhood (2013)](https://pubmed.ncbi.nlm.nih.gov/24371386/)
[Swerdlow RH, Mitochondria and mitochondrial cascades in Alzheimer's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/28190533/)